Tokyo

London

New York

finscreener facebook fan page

finscreener twitter page

finscreener linkedin page

AC Immune SA

TRADE

NASDAQ: ACIUHealthcare / Biotechnology / Switzerland
9.47-0.11-1.15%Vol 64 5481Y Perf -17.96%
Oct 18th, 2018 11:23
BID9.43 ASK9.47
Open9.50 Previous Close9.58
Pre-Market- After-Trading-
 - -%  - -%
Target Price
24.00 
Analyst Rating
Strong Buy 1.00
Potencial %
152.10 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12M
-/-/- 
Value Ranking
★★+     48.06
Insiders Value % 3/6/12M
-/-/- 
Growth Ranking
★★+     46.71
Insiders Shares Cnt. % 3/6/12M
-/-/- 
Income Ranking
 —    -
Market Cap (mil)624 
Earnings Rating
Strong Buy
Price Range Ratio 52wk %
22.56 
Earnings Date
12th Nov 2018

Today's Price Range

8.989.67

 

52wk Range

7.1617.40

Summary:

Buy

Technical Indicators: Neutral
Moving Averages: Strong Buy
Performance
1 Month
19.15%
3 Months
-18.68%
6 Months
-4.39%
1 Year
-17.96%
3 Years
-
5 Years
-

Quotes

Name / TickerPriceChg.Chg.%
ACIU9.47-0.1100-1.15
AAPL218.05-3.1400-1.42
GOOG1 095.00-20.6900-1.85
MSFT109.12-1.5900-1.44
XOM82.280.78000.96
WFC53.84-0.6200-1.14
JNJ138.72-0.7400-0.53
FB156.15-3.2700-2.05
GE12.370.18001.48
JPM109.33-0.5000-0.46
Financial StrengthValueIndustryS&P 500US Markets
Quick Ratio 9.40
Current Ratio 9.70
Long Term Debt to Total Capital 0.00
Total Debt to Equity 0.00
Interest Coverage -254.90
Leverage Ratio 1.20
ProfitabilityValueIndustryS&P 500US Markets
Gross Margin-
EBIT Margin-130.00
EBITDA Margin-126.30
Pre-tax Profit Margin-
Profit Margin-91.44
ValuationValueIndustryS&P 500US Markets
PE Ratio -
PB Ratio 6.03
PS Ratios 28.57
Price to Cash Flow 35.80
Price to Free Cash Flow -37.20
Cash Flow Per Share -0.38
Price to Tangible Book6.04
Book Value per Share1.43
Enterprise Value (in ths.)478 344
Management EffectivenessValueIndustryS&P 500US Markets
Return on Equity (5Y Avg)-
ROE last 12 Months -24.54
Return on Assets (5Y Avg) -
ROA last 12 Months -21.79
Return on Capital (5Y Avg) -
ROC last 12 Months -25.22
Return on invested Capital Q -11.06
Return on invested Capital Y-20.46
Assets Turnover0.10
Receivables Turnover8.60
RevenueValueIndustryS&P 500US Markets
Revenue LTM (in ths.)20 371
Revenue per Share 0.30
Revenue Growth 3 Years -21.44
Revenue Growth 5 Years -
DividendsValueIndustryS&P 500US Markets
Dividend Yield -
Dividend Rate -
Dividend Growth 3 Years-
Dividend Growth 5 Years-

Earnings HistoryEstimateReportedSurprise %
Q02 2018-0.23-0.2013.04
Q01 2018-0.23-0.2013.04
Q04 2017-0.06-
Q03 2017-0.20-0.1620.00
Q02 2017-0.07-0.22-214.29
Q01 2017-0.17-0.170.00
----
----
Earnings Per EndEstimateRevision %Trend
9/2018 QR-0.267.14Positive
12/2018 QR-0.273.57Positive
12/2018 FY-0.9311.43Positive
12/2019 FY-0.9413.76Positive
Next Report Date12th Nov 2018
Estimated EPS Next Report-0.26
Estimates Count2
EPS Growth Next 5 Years %-
Volume Overview
Volume64 548
Shares Outstanding (in ths.)65 860
Trades Count173
Dollar Volume541 541
Avg. Volume119 609
Avg. Weekly Volume135 785
Avg. Monthly Volume198 461
Avg. Quarterly Volume219 763

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

55%45%

Bearish Bullish

63%37%

Bearish Bullish

69%31%

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
2 (100.00 %)
2 (100.00 %)
2 (100.00 %)
Moderate Buy
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Hold
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
RatingStrong Buy
1.00
Strong Buy
1.00
Strong Buy
1.00

There are no comments yet.

News

x